Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.23
-0.53 (-9.20%)
At close: Apr 28, 2026, 4:00 PM EDT
5.25
+0.02 (0.38%)
After-hours: Apr 28, 2026, 6:47 PM EDT
Immuneering Employees
Immuneering had 53 employees as of December 31, 2025. The number of employees decreased by 13 or -19.70% compared to the previous year.
Employees
53
Change (1Y)
-13
Growth (1Y)
-19.70%
Revenue / Employee
n/a
Profits / Employee
-$1,057,074
Market Cap
338.37M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Silence Therapeutics | 88 |
| Armata Pharmaceuticals | 60 |
| X4 Pharmaceuticals | 45 |
| Surrozen | 44 |
| Compass Therapeutics | 39 |
| Avalo Therapeutics | 33 |
| Opus Genetics | 28 |
IMRX News
- 7 days ago - Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting - GlobeNewsWire
- 8 days ago - Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond - GlobeNewsWire
- 15 days ago - Immuneering Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 22 days ago - Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Immuneering to Present Molecular Data at 2026 AACR Annual Meeting from Atebimetinib-Treated Patients, Highlighting Mechanism Designed to Improve Durability and Survival - GlobeNewsWire
- 7 weeks ago - Immuneering Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Immuneering Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Immuneering to Present at the Leerink Global Healthcare Conference - GlobeNewsWire